Search - tctmd.com

Displaying 61 - 80 of 237

Sort: Relevancy | Date

Presentation TCT 2018

Approaches to Severe Mitral Annular Calcification: Transcatheter Repair or Replacement?

Presenter: Howard C. Herrmann, Vinod H. Thourani, Mayra Guerrero

September 24, 2018

Presentation TCT 2018

Addressing the Hurdles: Emerging Devices and Novel Valve Designs

Presenter: Howard C. Herrmann, Vinod H. Thourani

September 24, 2018

Presentation TCT 2018

Moving From Transapical to Transseptal Implantation: What Are the Technical and Anatomic Challenges, and Will We Get There?

Presenter: Howard C. Herrmann, Vinod H. Thourani, Jason H. Rogers

September 24, 2018

Presentation TCT 2018

Low Flow Low Gradient Aortic Stenosis Hemodynamic Pitfalls

Presenter: Morton J. Kern, Holger Thiele, Howard C. Herrmann

September 23, 2018

Presentation TCT 2018

Prosthesis-Patient Mismatch: Incidence, Predictors, and Outcome of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement

Presenter: Valentin Fuster, Howard C. Herrmann

September 23, 2018

Presentation TCT 2018

Choosing the Right TAVR for Your Patient

Presenter: Howard C. Herrmann

September 22, 2018

News Conference News ESC 2018

TAVR Debris Captured by Sentinel Embolic Protection Differs by Valve Type

Yael L. Maxwell

September 06, 2018

Presentation The Structural Heart Disease Summit 2018

US Perspectives

Presenter: Howard C. Herrmann

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR to Treat Pure Aortic Regurgitation: Published and Personal Experiences (With Case Examples)

Presenter: Howard C. Herrmann, Allan Schwartz, Eberhard Grube

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset

Presenter: Howard C. Herrmann, Allan Schwartz, Jonathan Afilalo

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

Presenter: Howard C. Herrmann, Allan Schwartz, Suzanne V. Arnold

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS

Presenter: Howard C. Herrmann, Allan Schwartz

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: Howard C. Herrmann, Allan Schwartz, Philippe Genereux

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: Howard C. Herrmann, Allan Schwartz, Nicolas M. Van Mieghem

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis

Presenter: Howard C. Herrmann, Allan Schwartz

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Counterpoint: A "Selective" Minimalist Strategy Makes More Sense, and "Extreme" Minimalism Is Dangerous!

Presenter: Eberhard Grube, Howard C. Herrmann, Susheel K. Kodali

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Point: A Minimalist Strategy Should Be Used in ALL TAVR Patients!

Presenter: Eberhard Grube, Howard C. Herrmann, Vinod H. Thourani

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The CARDIAQ Program: Attributes, Challenges, and Clinical Data

Presenter: Howard C. Herrmann

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

Presenter: Howard C. Herrmann, Fabian Nietlispach, Cenap Undemir, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Recurrent Leaflet Thrombosis After Sapien 3 Valve-in-Valve TAVR

Presenter: Howard C. Herrmann, Fabian Nietlispach, Hasan Ahmad, MD

June 21, 2018

Advertisement

Approaches to Severe Mitral Annular Calcification: Transcatheter Repair or Replacement?

Addressing the Hurdles: Emerging Devices and Novel Valve Designs

Moving From Transapical to Transseptal Implantation: What Are the Technical and Anatomic Challenges, and Will We Get There?

Low Flow Low Gradient Aortic Stenosis Hemodynamic Pitfalls

Prosthesis-Patient Mismatch: Incidence, Predictors, and Outcome of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement

Choosing the Right TAVR for Your Patient

TAVR Debris Captured by Sentinel Embolic Protection Differs by Valve Type

US Perspectives

TAVR to Treat Pure Aortic Regurgitation: Published and Personal Experiences (With Case Examples)

Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis

Counterpoint: A "Selective" Minimalist Strategy Makes More Sense, and "Extreme" Minimalism Is Dangerous!

Point: A Minimalist Strategy Should Be Used in ALL TAVR Patients!

The CARDIAQ Program: Attributes, Challenges, and Clinical Data

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

Recurrent Leaflet Thrombosis After Sapien 3 Valve-in-Valve TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content